due to this tumor cell heterogeneity , the direction of future studies should be towards combining androgen ablation plus chemotherapy early in the disease in order to affect both the androgen-dependent and -independent cancer cells present within individual prostatic cancers .
C0334227
cancer cells
C0376358
prostatic cancers